Abstract
About 35% reduction in cancer deaths among patients having solid tumors is related to using aspirin, which encouraged us to develop a new specific tumor diagnostic radiopharmaceutical agent. This can be done by direct labeling of aspirin with technetium-99m using stannous chloride as a reductant at pH 9. At this pH, aspirin is saponificated to salicylate ions. Salicylate binds to pertechenetate to form 99mTc salicylate complex. The radiochemical yield (RCY, %) of 99mTc-salicylate complex obtained from aspirin was determined using paper chromatography, electrophoresis, and HPLC and was found to reach 90.2%. The 99mTc salicylate complex obtained from aspirin was stable for up to 5 h. The tumor uptake of the 99mTc salicylate complex obtained from aspirin was determined by ex-vivo study in tumor-bearing mice. This study showed that 99mTc salicylate complex was concentrated in tumor sites (ascites or solid), allowing tumor radioimaging. High target/non-target (tumor muscles/normal muscles) uptake ratio shows that 99mTc salicylate complex can be utilized for early detection of solid tumors. Molecular modeling and docking study conofirm the possibility of using the radiolabeled 99mTc salicylate complex for specific cancer imaging in binding with epidermal growth factor receptors (EGFR).
Similar content being viewed by others
REFERENCES
Bernhard, W., El-Sayed, A., Barreto, K., et al., Oncotarget, 2018, vol. 9, no. 5, pp. 6213–6227.
Gao, M., Su, H., Lin, G., et al., Nanoscale, 2016, vol. 8, no. 32, pp. 15027–15032.
Drugs.com: American Society of Health-System Pharmacists, June 6, 2016. Retrieved Aug. 30, 2016.
Krumholz, A., Sung, G.Y., Fisher, R.S., et al., Neurology, 1995, vol. 45, pp. 1499–1505.
Kassis, A.I., Exper tOpin. Drug Deliv., 2005, vol. 2, no. 6, pp. 981–991.
El-Ghany, E.A., Mahdy, M.A., Attallah, K., and Ghazy, F.S., J. Radioanal. Nucl. Chem., 2002, vol. 252, no. 1, pp. 165–169.
Motaleb, M.A., Moustapha, M.E., and Ibrahim, I.T., J. Radioanal. Nucl Chem., 2011, vol. 289, no. 7, pp. 239–245.
Liu, F.E.I., Youfeng, H.E., and Luo, Z., IAEA Tech. Rep. Ser., 2004, no. 426, pp. 37–52.
Greenwood, N. and Earnshaw, A., Origin of the Elements, Isotopes and Atomic Weights,Chemistry of theElements, Oxford: Elsevier, 1997.
Bodei, L., Cremonesi, M., Zoboli, S., et al., Eur. J. Nucl. Med. Mol. Imaging, 2003, vol. 30, pp. 207–216.
Jovanović, V., Maksin, T., Konstantinovska, D., et al., J. Radioanal Nucl. Chem., 1980, vol. 59, no. 1, pp. 239–243.
Motaleb, M.A., El-Kolaly, M.T., Rashed, H.M., and Abd El-Bary, A., J. Radioanal. Nucl. Chem., 2012, vol. 292, pp. 629–635.
Jack, D.B., Lancet, 1997, vol. 350, no. 9075, pp. 437–439.
Schenone, A.L. and Lincoff, A.M., Cleveland Clinic J. Med., 2020 vol. 87, no. 5, p. 300311
Andrew, T., Peters, M.D., and Kannan, R.M., JAMA, 2020, vol. 323, no. 7, p. 676
Cao, Y., and Tan, A., Medicine, 2020, vol. 99, no. 38, p. e21917.
Langley, R.E., Burdett, S., Tierney, J.F., et al., Br. J. Cancer, 2011, vol. 105, no. 8, pp. 1107–1113.
Langley, R.E., Ecancer, 2013, vol. 7, pp. 297–303.
Song, Y., Zhong, X., Gao, P., et al., Front. Endocrinol., 2020, vol. 11, ID 3.
Algra, A.M. and Rothwell, P.M., Lancet Oncology, 2012, vol. 13, no. 5, pp. 518–527.
Burn, J., Sheth, H., Elliott, F., et al., Lancet, 2020, vol. 395, pp. 1855–1863.
Rothwell, P.M., Wilson, M., Price, J.F., et al., Lancet, 2012, vol. 379, pp. 1591–1601.
Huang, L., Gainkam L.O., Caveliers, V., et al., Mol. Imaging Biol., 2008, vol. 10, no. 3, pp. 167–175.
Ferrit, M., del Valle, C., and Martínez, F., Eur. J. Pharm. Sci., 2007, vol. 31, nos. 3–4, pp. 211–220.
Kamal, O., Benlyamani, A., Serdaoui, F., Riri, M., and Cherif, A., Open J. Phys. Chem., 2012, vol. 2, pp. 81–87.
Ibrahim, I.T., Attallah, K.H., Elsaid, M., et al., Radiochemistry, 2019, vol. 61, no. 2, pp. 220–225.
Ibrahim, I.T. and Wally, M.A., J. Radioanal. Nucl. Chem., 2010, vol. 285, pp. 169–175.
Sanad, M.H., Saad, M.M., Fouzy, A.S.M., et al., J. Mol. Imaging Dyn., 2016, vol. 6, ID 2.
Moustapha, E.M., Motaleb, M., and Ibrahim, I.T., J. Radioanal. Nucl. Chem., 2011, vol. 287, pp. 35–40.
Othman, S.H., Ibrahim, I.T., Hatab, M.H., and El-Barbary, A.M., Int. J. Biol. Macromol., 2016, vol. 92, pp. 550–560.
Tamirat, M.Z., Koivu, M., Elenius, K., and Johnson, M.S., PLoS One, 2019, vol. 14, no. 9, p. e0222814
Khedr, M.A., Rashed, H.M., Farag, H., and Sakr, T.M., Bioorg. Chem., 2019, vol. 92, ID 103282.
Abd Elhalim, S.M. and Ibrahim, I.T., Appl. Radiat. Isot., 2015, vol. 95, pp. 153–158.
Amin, A.M., Ibrahim, I.T. and Attallah, K.M., Radiochemistry, 2014, vol. 56, no. 1, pp. 72–75.
Schibli, R., Bella, R.L., Alberto, R., Garcia-Garayoa, E., Ortner, K., Abram, U., and Schubiger, P.A., Bioconjugate Chem., 2000, vol. 11, no. 3, pp. 345–351.
Alfonso, L., Ai, G., Spitale, R., and Bhat, G., Brit. J. Cancer, 2014, vol. 111, no. 1, pp. 61–67.
Bashir, A.I., Kankipati, C.S., Jones, S., et al., Int. J. Oncol., 2019, vol. 54, no. 4, pp. 1256–1270.
Zhang, X., Feng, Y., Liu, X., et al., J. Cancer Res. Clin. Oncol., 2019, vol. 145, pp. 1387–1403.
Funding
The study was financially supported by the Deanship of Scientific Research at Umm Al-Qura University, Makkah, Saudi Arabia (grant code: 19-MED-1-01-0038).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Dawoud, M., Attallah, K.M., Abdelhalim, S.M. et al. Labeling of Aspirin with 99mTc to Obtain a Possible Tumor Imaging Agent. Radiochemistry 63, 820–827 (2021). https://doi.org/10.1134/S106636222106014X
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S106636222106014X